Abstract
The preferred method for shunting cerebrospinal fluid in the ventricles is via a ventriculoperitoneal or ventriculoatrial shunt. Unfortunately, infection is a major complication of shunt surgery, which places the patient at risk of intellectual impairment and death. Although the most common causative pathogens are Staphylococcus epidermidis and Staphylococcus aureus , gram-negative bacterial infections have increased over the last three decades. Treatment of Pseudomonas ventriculitis is highly variable, because there are few guidelines for drug selection, administration, and monitoring. We report a case of post-shunt revision Pseudomonas meningitis/ ventriculitis that was successfully treated by the intraventricular adminstration tobramycin in conjunction with intravenous tobramycin and ceftazidime.
Cite
CITATION STYLE
Masvosva, P., Buckingham, S. C., Einhaus, S., & Phelps, S. J. (2012). Intraventricular and Intravenous Tobramycin with Ceftazidime for Ventriculitis Secondary to Pseudomonas aeruginosa. The Journal of Pediatric Pharmacology and Therapeutics, 8(2), 138–143. https://doi.org/10.5863/1551-6776-8.2.138
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.